12.88 -0.54 (-4.05%)
AMLN
Stock Details
Last Trade:12.88 Change:-0.54 (-4.05%) Prev Close:13.42 Open: 13.34 Days Range:12.83 – 13.34 52 Week Range: 5.50 - 35.00 Volume:2307624 P/E: N/AEPS:-2.14
View AllRecent Alerts 07/02/09
Recent Alert on 06/26/09 at 1:58pm
Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
Several stocks with products related to the treatment of diabetes are seeing unusual investor interest today amid reports out of Europe that an unidentified clinical study showed long-acting insulin users may have increased risks to cancer. As... Read More
Recent Alert on 06/26/09 at 1:58pm
Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
Recent Alert on 06/26/09 at 12:39pm
Unusual 11 Mid-Day Movers 6/26: NCS, PALM, SCON, AMLN Higher; DWRI, GRB, BLUD, RBN Lower
Unusual 11 Mid-Day Movers 6/26: NCS, PALM, SCON, AMLN Higher; DWRI, GRB, BLUD, RBN Lower
Recent Alert on 06/08/09 at 5:36pm
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
Recent Alert on 06/08/09 at 5:36pm
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available